Self-induced accumulation of glutamate in striatal astrocytes and basal ganglia excitotoxicity

GLIA

Volumn 60, Issue 10, 2012, Pages 1481-1494

  Morales, Ingrid ^a,b   Rodriguez, Manuel ^a,b  

^a UNIVERSIDAD DE LA LAGUNA   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

Author keywords

Astrocyte; Excitotoxicity; Glutamate; Striatum

Indexed keywords

ALANINE; GLUTAMATE AMMONIA LIGASE; GLUTAMIC ACID; GLUTAMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; ASTROCYTOSIS; BASAL GANGLION; BIOACCUMULATION; BIOCHEMISTRY; CORPUS STRIATUM; DIALYSATE; EXCITOTOXICITY; GLIOSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; IMMUNOREACTIVITY; IN VIVO STUDY; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT;

ANALYSIS OF VARIANCE; ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; ASTROCYTES; BASAL GANGLIA; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMATE-AMMONIA LIGASE; GLUTAMIC ACID; MALE; MICRODIALYSIS; NEUROTOXICITY SYNDROMES; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 84865320895     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22368     Document Type: Article

References (74)

1. Albin RL, Reiner A, Anderson KD, Dure LSt, Handelin B, Balfour R, Whetsell WOJr, Penney JB, Young AB. 1992. Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington's disease. Ann Neurol 31: 425-430.
2. Albrecht J, Sonnewald U, Waagepetersen HS, Schousboe A. 2007. Glutamine in the central nervous system: Function and dysfunction. Front Biosci 12: 332-343.
3. Andre VM, Cepeda C, Levine MS. 2010. Dopamine and glutamate in Huntington's disease: A balancing act. CNS Neurosci Ther 16: 163-178.
4. Beal MF, Kowall NW, Ellison DW, Mazurek MF, Swartz KJ, Martin JB. 1986. Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature 321: 168-171.
5. Beal MF, Kowall NW, Swartz KJ, Ferrante RJ, Martin JB. 1988. Systemic approaches to modifying quinolinic acid striatal lesions in rats. J Neurosci 8: 3901-3908.
6. Behrstock S, Ebert A, McHugh J, Vosberg S, Moore J, Schneider B, Capowski E, Hei D, Kordower J, Aebischer P, Svendsen CN. 2006. Human neural progenitors deliver glial cell line-derived neurotrophic factor to parkinsonian rodents and aged primates. Gene Ther 13: 379-388.
7. Bezzi P, Carmignoto G, Pasti L, Vesce S, Rossi D, Rizzini BL, Pozzan T, Volterra A. 1998. Prostaglandins stimulate calcium-dependent glutamate release in astrocytes. Nature 391: 281-285.
8. Bezzi P, Gundersen V, Galbete JL, Seifert G, Steinhauser C, Pilati E, Volterra A. 2004. Astrocytes contain a vesicular compartment that is competent for regulated exocytosis of glutamate. Nat Neurosci 7: 613-620.
9. Bush TG, Puvanachandra N, Horner CH, Polito A, Ostenfeld T, Svendsen CN, Mucke L, Johnson MH, Sofroniew MV. 1999. Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice. Neuron 23: 297-308.
10. Coyle JT. 1987. Kainic acid: Insights into excitatory mechanisms causing selective neuronal degeneration. Ciba Found Symp 126: 186-203.
11. Coyle JT, Schwarcz R. 1976. Lesion of striatal neurones with kainic acid provides a model for Huntington's chorea. Nature 263: 244-246.
12. Chojnacki A, Weiss S. 2008. Production of neurons, astrocytes and oligodendrocytes from mammalian CNS stem cells. Nat Protoc 3: 935-940.
13. Danbolt NC. 2001. Glutamate uptake. Prog Neurobiol 65: 1-105.
14. de Groot J, Sontheimer H. 2011. Glutamate and the biology of gliomas. Glia 59: 1181-1189.
15. Del Arco A, Segovia G, Fuxe K, Mora F. 2003. Changes in dialysate concentrations of glutamate and GABA in the brain: An index of volume transmission mediated actions? J Neurochem 85: 23-33.
16. Doetsch F, Caille I, Lim DA, Garcia-Verdugo JM, Alvarez-Buylla A. 1999. Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell 97: 703-716.
17. Douaud G, Behrens TE, Poupon C, Cointepas Y, Jbabdi S, Gaura V, Golestani N, Krystkowiak P, Verny C, Damier P, Bachoud-Lévi AC, Hantraye P, Remy P. 2009. In vivo evidence for the selective subcortical degeneration in Huntington's disease. Neuroimage 46: 958-966.
18. During MJ, Ryder KM, Spencer DD. 1995. Hippocampal GABA transporter function in temporal-lobe epilepsy. Nature 376: 174-177.
19. Foran E, Trotti D. 2009. Glutamate transporters and the excitotoxic path to motor neuron degeneration in amyotrophic lateral sclerosis. Antioxid Redox Signal 11: 1587-1602.
20. Garcia AD, Doan NB, Imura T, Bush TG, Sofroniew MV. 2004. GFAP-expressing progenitors are the principal source of constitutive neurogenesis in adult mouse forebrain. Nat Neurosci 7: 1233-1241.
21. Garcia Dopico J, Perdomo Diaz J, Alonso TJ, Gonzalez Hernandez T, Castro Fuentes R, Rodriguez Diaz M. 2004. Extracellular taurine in the substantia nigra: taurine-glutamate interaction. J Neurosci Res 76: 528-538.
22. Haas J, Erdo SL. 1991. Quisqualate-induced excitotoxic death of glial cells: transient vulnerability of cultured astrocytes. Glia 4: 111-114.
23. Halliday GM, Stevens CH. 2011. Glia: Initiators and progressors of pathology in Parkinson's disease. Mov Disord 26: 6-17.
24. Hansen DV, Lui JH, Parker PR, Kriegstein AR. 2010. Neurogenic radial glia in the outer subventricular zone of human neocortex. Nature 464: 554-561.
25. Hazell AS. 2007. Excitotoxic mechanisms in stroke: an update of concepts and treatment strategies. Neurochem Int 50: 941-953.
26. Hourani BT, Hamlin EM, Reynolds TB. 1971. Cerebrospinal fluid glutamine as a measure of hepatic encephalopathy. Arch Intern Med 127: 1033-1036.
27. Jenner P, Olanow CW. 1998. Understanding cell death in Parkinson's disease. Ann Neurol 44: S72-S84.
28. Kassubek J, Juengling FD, Ecker D, Landwehrmeyer GB. 2005. Thalamic atrophy in Huntington's disease co-varies with cognitive performance: A morphometric MRI analysis. Cereb Cortex 15: 846-853.
29. Keefe KA, Sved AF, Zigmond MJ, Abercrombie ED. 1993. Stress-induced dopamine release in the neostriatum: Evaluation of the role of action potentials in nigrostriatal dopamine neurons or local initiation by endogenous excitatory amino acids. J Neurochem 61: 1943-1952.
30. Kriegstein A, Alvarez-Buylla A. 2009. The glial nature of embryonic and adult neural stem cells. Annu Rev Neurosci 32: 149-184.
31. Lemberg A, Fernandez MA. 2009. Hepatic encephalopathy, ammonia, glutamate, glutamine and oxidative stress. Ann Hepatol 8: 95-102.
32. Liu X, Bolteus AJ, Balkin DM, Henschel O, Bordey A. 2006. GFAP-expressing cells in the postnatal subventricular zone display a unique glial phenotype intermediate between radial glia and astrocytes. Glia 54: 394-410.
33. Lois C, Alvarez-Buylla A. 1993. Proliferating subventricular zone cells in the adult mammalian forebrain can differentiate into neurons and glia. Proc Natl Acad Sci USA 90: 2074-2077.
34. Lowy MT, Gault L, Yamamoto BK. 1993. Adrenalectomy attenuates stress-induced elevations in extracellular glutamate concentrations in the hippocampus. J Neurochem 61: 1957-1960.
35. Marcaggi P, Attwell D. 2004. Role of glial amino acid transporters in synaptic transmission and brain energetics. Glia 47: 217-225.
36. Marti M, Sbrenna S, Fuxe K, Bianchi C, Beani L, Morari M. 2000. Increased responsivity of glutamate release from the substantia nigra pars reticulata to striatal NMDA receptor blockade in a model of Parkinson's disease. A dual probe microdialysis study in hemiparkinsonian rats. Eur J Neurosci 12: 1848-1850.
37. Mates JM, Segura JA, Campos-Sandoval JA, Lobo C, Alonso L, Alonso FJ, Marquez J. 2009. Glutamine homeostasis and mitochondrial dynamics. Int J Biochem Cell Biol 41: 2051-2061.
38. Matute C. 1998. Characteristics of acute and chronic kainate excitotoxic damage to the optic nerve. Proc Natl Acad Sci USA 95: 10229-10234.
39. Matute C, Domercq M, Sanchez-Gomez MV. 2006. Glutamate-mediated glial injury: Mechanisms and clinical importance. Glia 53: 212-224.
40. McCarty MF. 2006. Down-regulation of microglial activation may represent a practical strategy for combating neurodegenerative disorders. Med Hypotheses 67: 251-269.
41. McDonald JW, Althomsons SP, Hyrc KL, Choi DW, Goldberg MP. 1998. Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity. Nat Med 4: 291-297.
42. McGeer EG, McGeer PL, Singh K. 1978. Kainate-induced degeneration of neostriatal neurons: Dependency upon corticostriatal tract. Brain Res 139: 381-383.
43. McGeer PL, McGeer EG. 2008. Glial reactions in Parkinson's disease. Mov Disord 23: 474-483.
44. Meshul CK, Emre N, Nakamura CM, Allen C, Donohue MK, Buckman JF. 1999. Time-dependent changes in striatal glutamate synapses following a 6-hydroxydopamine lesion. Neuroscience 88: 1-16.
45. Morales I, Fuentes A, Gonzalez-Hernandez T, Rodriguez M. 2009. Osmosensitive response of glutamate in the substantia nigra. Exp Neurol 220: 335-340.
46. Obeso JA, Rodriguez-Oroz MC, Benitez-Temino B, Blesa FJ, Guridi J, Marin C, Rodriguez M. 2008. Functional organization of the basal ganglia: therapeutic implications for Parkinson's disease. Mov Disord 23 Suppl 3: S548-S559.
47. Obeso JA, Rodriguez-Oroz MC, Goetz CG, Marin C, Kordower JH, Rodriguez M, Hirsch EC, Farrer M, Schapira AH, Halliday G. 2010. Missing pieces in the Parkinson's disease puzzle. Nat Med 16: 653-661.
48. Obrenovitch TP, Richards DA. 1995. Extracellular neurotransmitter changes in cerebral ischaemia. Cerebrovasc Brain Metab Rev 7: 1-54.
49. Obrenovitch TP, Urenjak J. 1997. Altered glutamatergic transmission in neurological disorders: From high extracellular glutamate to excessive synaptic efficacy. Prog Neurobiol 51: 39-87.
50. Olanow CW, Tatton WG. 1999. Etiology and pathogenesis of Parkinson's disease. Annu Rev Neurosci 22: 123-144.
51. Ortinski PI, Dong J, Mungenast A, Yue C, Takano H, Watson DJ, Haydon PG, Coulter DA. 2010. Selective induction of astrocytic gliosis generates deficits in neuronal inhibition. Nat Neurosci 13: 584-591.
52. Perry VH, Bell MD, Brown HC, Matyszak MK. 1995. Inflammation in the nervous system. Curr Opin Neurobiol 5: 636-641.
53. Raivich G, Bohatschek M, Kloss CU, Werner A, Jones LL, Kreutzberg GW. 1999. Neuroglial activation repertoire in the injured brain: graded response, molecular mechanisms and cues to physiological function. Brain Res Brain Res Rev 30: 77-105.
54. Rappold PM, Tieu K. 2010. Astrocytes and therapeutics for Parkinson's disease. Neurotherapeutics 7: 413-423.
55. Reynolds BA, Weiss S. 1992. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 255: 1707-1710.
56. Robinson MB. 1998. The family of sodium-dependent glutamate transporters: a focus on the GLT-1/EAAT2 subtype. Neurochem Int 33: 479-491.
57. Rodriguez Diaz M, Alonso TJ, Perdomo Diaz J, Gonzalez Hernandez T, Castro Fuentes R, Sabate M, Garcia Dopico J. 2005. Glial regulation of nonsynaptic extracellular glutamate in the substantia nigra. Glia 49: 134-142.
58. Rodriguez M, Morales I, Gomez I, Gonzalez S, Gonzalez-Hernandez T, Gonzalez-Mora JL. 2006. Heterogeneous dopamine neurochemistry in the striatum: the fountain-drain matrix. J Pharmacol Exp Ther.
59. Rodriguez MC, Obeso JA, Olanow CW. 1998. Subthalamic nucleus-mediated excitotoxicity in Parkinson's disease: a target for neuroprotection. Ann Neurol 44: S175-S188.
60. Rothstein JD, Dykes-Hoberg M, Pardo CA, Bristol LA, Jin L, Kuncl RW, Kanai Y, Hediger MA, Wang Y, Schielke JP, Welty Df. 1996. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16: 675-686.
61. Saulskaya N, Marsden CA. 1995. Extracellular glutamate in the nucleus accumbens during a conditioned emotional response in the rat. Brain Res 698: 114-120.
62. Scheffler B, Walton NM, Lin DD, Goetz AK, Enikolopov G, Roper SN, Steindler DA. 2005. Phenotypic and functional characterization of adult brain neuropoiesis. Proc Natl Acad Sci USA 102: 9353-9358.
63. Shinohara K, Honma S, Katsuno Y, Honma K. 2000. Circadian release of excitatory amino acids in the suprachiasmatic nucleus culture is Ca(2+)-independent. Neurosci Res 36: 245-250.
64. Sofroniew MV. 2009. Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci 32: 638-647.
65. Sofroniew MV, Vinters HV. 2010. Astrocytes: Biology and pathology. Acta Neuropathol 119: 7-35.
66. Streit WJ, Walter SA, Pennell NA. 1999. Reactive microgliosis. Prog Neurobiol 57: 563-581.
67. Suzuki SO, Goldman JE. 2003. Multiple cell populations in the early postnatal subventricular zone take distinct migratory pathways: A dynamic study of glial and neuronal progenitor migration. J Neurosci 23: 4240-4250.
68. Swanson RA, Ying W, Kauppinen TM. 2004. Astrocyte influences on ischemic neuronal death. Curr Mol Med 4: 193-205.
69. Teismann P, Schulz JB. 2004. Cellular pathology of Parkinson's disease: astrocytes, microglia and inflammation. Cell Tissue Res 318: 149-161.
70. Tucci S, Rada P, Hernandez L. 1998. Role of glutamate in the amygdala and lateral hypothalamus in conditioned taste aversion. Brain Res 813: 44-49.
71. Vesce S, Rossi D, Brambilla L, Volterra A. 2007. Glutamate release from astrocytes in physiological conditions and in neurodegenerative disorders characterized by neuroinflammation. Int Rev Neurobiol 82: 57-71.
72. Xu J, Peng H, Kang N, Zhao Z, Lin JH, Stanton PK, Kang J. 2007. Glutamate-induced exocytosis of glutamate from astrocytes. J Biol Chem 282: 24185-24197.
73. Yoshioka A, Hardy M, Younkin DP, Grinspan JB, Stern JL, Pleasure D. 1995. Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptors mediate excitotoxicity in the oligodendroglial lineage. J Neurochem 64: 2442-2448.
74. Zhang RL, LeTourneau Y, Gregg SR, Wang Y, Toh Y, Robin AM, Zhang ZG, Chopp M. 2007. Neuroblast division during migration toward the ischemic striatum: A study of dynamic migratory and proliferative characteristics of neuroblasts from the subventricular zone. J Neurosci 27: 3157-3162.